Dimensional Fund Advisors
JSPR icon

Dimensional Fund Advisors’s Jasper Therapeutics JSPR Stock Holding History

Dimensional Fund Advisors’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,664
Closed -$16.4K – 3273
2026
Q1 		$16.4K Hold
18,664
– – ﹤0.01% 3211
2025
Q4 		$34.2K Sell
18,664
-20,299
-52% -$40.8K ﹤0.01% 3224
2025
Q3 		$92.7K Sell
38,963
-5,698
-13% -$17.3K ﹤0.01% 3199
2025
Q2 		$248K Hold
44,661
– – ﹤0.01% 3087
2025
Q1 		$192K Buy
44,661
+6,956
+18% +$46.3K ﹤0.01% 3135
2024
Q4 		$806K Buy
37,705
+780
+2% +$16.2K ﹤0.01% 2954
2024
Q3 		$695K Buy
+36,925
New +$735K ﹤0.01% 2976

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors's JSPR Position: Q2 2026 in Review

Dimensional Fund Advisors sold out of Jasper Therapeutics (JSPR) in Q2 2026, closing a stake of 18,664 shares — an estimated $16.4K sold.

Dimensional Fund Advisors first reported a position in JSPR in Q3 2024 and held it in 7 quarters. The position peaked at $806K in Q4 2024. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Dimensional Fund Advisors reported no remaining Jasper Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 18,664 Jasper Therapeutics shares in Q2 2026, an estimated $16.4K.
  • Dimensional Fund Advisors first reported a position in Jasper Therapeutics in Q3 2024 and held it in 7 quarters.
  • Dimensional Fund Advisors's Jasper Therapeutics position peaked at $806K in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.